Increased expression of ganglioside GM1 in peripheral CD4+ t cells correlates soluble form of CD30 in systemic lupus erythematosus patients

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Dong, Lingli ^a   Hu, Shaoxian ^a   Chen, Fang ^a   Lei, Xiaomei ^a   Tu, Wei ^a   Yu, Yikai ^a   Yang, Liu ^a   Sun, Wei ^a   Yamaguchi, Takuro ^b   Masaki, Yasufumi ^c   Umehara, Hisanori ^c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b KANSAI ELECTRIC POWER CO   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45RO ANTIGEN; CD8 ANTIGEN; GANGLIOSIDE GM1; INTERLEUKIN 10; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA; CD30 ANTIGEN; IMMUNOGLOBULIN G;

ANALYTICAL PARAMETERS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; IN VITRO STUDY; LIPID RAFT; MEMORY T LYMPHOCYTE; PATHOGENESIS; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; CELL MEMBRANE; DRUG EFFECT; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; KINETICS; LYMPHOCYTE ACTIVATION; SOLUBILITY; TIME;

ANTIGENS, CD30; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; G(M1) GANGLIOSIDE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; INTERLEUKIN-10; KINETICS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MEMBRANE MICRODOMAINS; PHYTOHEMAGGLUTININS; SOLUBILITY; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955346976     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/569053     Document Type: Article

References (28)

1. Yazdany J., Panopalis P., Gillis J. Z., Schmajuk G., MacLean C. H., Wofsy D., Yelin E., A quality indicator set for systemic lupus erythematosus Arthritis & Rheumatism 2009 61 3 370 377
2. Hoffman R. W., T cells in the pathogenesis of systemic lupus erythematosus Clinical Immunology 2004 113 1 4 13
3. La Cava A., Lupus and T cells Lupus 2009 18 3 196 201
4. Alonso M. A., Milln J., The role of lipid rafts in signalling and membrane trafficking in T lymphocytes Journal of Cell Science 2001 114 22 3957 3965
5. Kabouridis P. S., Jury E. C., Lipid rafts and T-lymphocyte function: implications for autoimmunity FEBS Letters 2008 582 27 3711 3718
6. Jacobson K., Mouritsen O. G., Anderson R. G. W., Lipid rafts: at a crossroad between cell biology and physics Nature Cell Biology 2007 9 1 7 14
7. Mossman K. D., Campi G., Groves J. T., Dustin M. L., Altered TCR signaling from geometrically repatterned immunological synapses Science 2005 310 5751 1191 1193
8. Pavón E.J.,Muñoz P. Navarro M.-D.-C., Raya-Alvarez E., Callejas-Rubio J.-L., Navarro-Pelayo F., Ortego-Centeno N., Sancho J., Zubiaur M., Increased association of CD38 with lipid rafts in T cells from patients with systemic lupus erythematosus and in activated normal T cells Molecular Immunology 2006 43 7 1029 1039
9. Jury E. C., Kabouridis P. S., Flores-Borja F., Mageed R. A., Isenberg D. A., Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus Journal of Clinical Investigation 2004 113 8 1176 1187
10. Purdue M. P., Lan Q., Martinez-Maza O., Oken M. M., Hocking W., Huang W.-Y., Baris D., Conde B., Rothman N., A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma Blood 2009 114 13 2730 2732
11. Ciferská H., Horák P., Hemanová Z., Ordeltov M., Zadrail J., Tich T., udla V., The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value Clinical Rheumatology 2007 26 5 723 728
12. Savolainen E., Matinlauri I., Kautiainen H., Luosujärvi R., Kaipiainen-Seppnen O., Serum soluble CD30 in early arthritis: a sign of inflammation but not a predictor of outcome Clinical and Experimental Rheumatology 2008 26 5 922 925
13. Tan E. M., Cohen A. S., Fries J. F., The 1982 revised criteria for the classification of systemic lupus erythrematosus Arthritis and Rheumatism 1982 25 11 1271 1277
14. Bombardier C., Gladman D. D., Urowitz M. B., Caron D., Chang C. H., Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE Arthritis Rheumatism 1992 35 630 640
15. Jin Z.-X., Huang C.-R., Dong L., Goda S., Kawanami T., Sawaki T., Sakai T., Tong X.-P., Masaki Y., Fukushima T., Tanaka M., Mimori T., Tojo H., Bloom E. T., Okazaki T., Umehara H., Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells International Immunology 2008 20 11 1427 1437
16. Dong L., Masaki Y., Takegami T., Jin Z.-X., Huang C.-R., Fukushima T., Sawaki T., Kawanami T., Saeki T., Kitagawa K., Sugai S., Okazaki T., Hirose Y., Umehara H., Clonality analysis of lymphoproliferative disorders in patients with Sj̈gren's syndrome Clinical and Experimental Immunology 2007 150 2 279 284
17. Dong L., Masaki Y., Takegami T., Kawanami T., Itoh K., Jin Z.-Y., Huang C.-R., Tong X.-P., Fukushima T., Tanaka M., Sawaki T., Sakai T., Sugai S., Okazaki T., Hirose Y., Umehara H., Cloning and expression of two human recombinant monoclonal Fab fragments specific for EBV viral capsid antigen International Immunology 2007 19 3 331 336
18. Janes P. W., Ley S. C., Magee A. I., Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor Journal of Cell Biology 1999 147 2 447 461
19. Kovacs B., Maus M. V., Riley J. L., Derimanov G. S., Koretzky G. A., June C. H., Finkel T. H., Human CD8+ T cells do not require the polarization of lipid rafts for activation and proliferation Proceedings of the National Academy of Sciences of the United States of America 2002 99 23 15006 15011
20. Tenbrock K., Juang Y.-T., Kyttaris V. C., Tsokos G. C., Altered signal transduction in SLE T cells Rheumatology 2007 46 10 1525 1530
21. Noraz N., Schwarz K., Steinberg M., Dardalhon V., Rebouissou C., Hipskind R., Friedrich W., Yssel H., Bacon K., Taylor N., Alternative antigen receptor (TCR) signaling in T cells derived from ZAP-70-deficient patients expressing high levels of Syk Journal of Biological Chemistry 2000 275 21 15832 15838
22. Jury E. C., Flores-Borja F., Kabouridis P. S., Lipid rafts in T cell signalling and disease Seminars in Cell and Developmental Biology 2007 18 5 608 615
23. Rezaei N., Haji-Molla-Hoseini M., Aghamohammadi A., Pourfathollah A. A., Moghtadaie M., Pourpak Z., Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications Journal of Clinical Immunology 2008 28 1 78 84
24. Caligaris-Cappio F., Bertero M. T., Converso M., Stacchini A., Vinante F., Romagnani S., Pizzolo G., Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity Clinical and Experimental Rheumatology 1995 13 3 339 343
25. Von Tresckow B., Kallen K.-J., Von Strandmann E. P., Borchmann P., Lange H., Engert A., Hansen H. P., Depletion of cellular cholesterol and lipid rafts increases shedding of CD30 Journal of Immunology 2004 172 7 4324 4331
26. Solgi G., Amirzagar A. A., Pourmand G., Mehrsai A. R., Taherimahmoudi M., Baradaran N., Nicknam M. H., Ebrahimi Rad M. R., Saraji A., Asadpoor A. A., Moheiydin M., Nikbin B., TH1/TH2 cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion Transplantation Proceedings 2009 41 7 2800 2804
27. Gerli R., Lunardi C., Bocci E. B., Bobbio-Pallavicini F., Schillaci G., Caporali R., Bistoni O., Pirro M., Pitzalis C., Montecucco C., Anti-tumor necrosis factor- response in rheumatoid arthritis is associated with an increase in serum soluble CD30 Journal of Rheumatology 2008 35 1 14 19
28. Dolff S., Abdulahad W. H., Bijl M., Kallenberg C. G. M., Regulators of B-cell activity in SLE: a better target for treatment than B-cell depletion? Lupus 2009 18 7 575 580